米国市場銘柄情報

SLN サイレンス・セラピューティクス

銘柄追加

21.880
+0.275+1.27%

終値 04/29 16:00 ET

21.880
0.0000.00%

市場後 16:00 ET

10.20億時価総額-15006直近PER

サイレンス・セラピューティクスに関するコメント

ログインコメントを投稿

Moomoo AI

02/03 20:08

Despite strong growth, Silence Therapeutics' high P/S ratio and weak revenue outlook suggest a risk of share price decline. Analysts lack confidence in a business turnaround, indicating potential risk for shareholders and potential investors.

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 26% But Growth Is Lacking

Moomoo AI

2023/11/27 18:17

Analysts' confidence appears low for Silence Therapeutics' business turnaround. The high P/S ratio and expected revenue decline suggest unsustainable current price levels which may erode current sentiment towards the stock.

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 65% But Growth Is Lacking

Trytosaveabit

2023/11/01 19:13

News

$サイレンス・セラピューティクス(SLN.US)$ Silence Therapeutics Reports Topline Results From Phase 1 Multiple Dose Study Of Zerlasiran; Lp(a) Levels Remained Around 90% Lower Than Baseline At Study Endpoint